|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Uricase and other novel agents for the management of patients with treatment-failure gout 显示文摘 | Sundy J S Hershfield M S | 2007 | Curr Rheumatol2007，9，： | 1 |
| 2 | Update on nonstefiodal anti-inflammtory drugs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr opin Rheumatol2006，18，3： | 1 |
| 3 | 显示文摘 | Sempowski GD Hale LP Sundy JS | 2000 | J Immunol2000，164，： | 1 |
| 4 | Pharmacolinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthr Rheum2007，56，： | 1 |
| 5 | Characterizationofoatcalmodulinandradioimmunoassayofitssubcellulardistribution显示文摘 | BiroRL SunDY SerlinBSetal | 1984 | PlantPhysiol1984，75，： | 1 |
| 6 | Efficacy and safety of lesinuard (RDEA594), a novel uricosuric agent in combination with allopurinol in allopurinol referactory gout patients: randomized, blinded, placebo-controlled, phase 2B extension study 显示文摘 | Perez-Ruiz F Sundy J Krishnan E | 2013 | Ann Rheum Dis2013，71，： | 1 |
| 7 | The interleukin 1 inhibitor rilonacept in treatment of chronic gout- y arthritis: results of a placebo-controlled, monosequence cross over, non-randomised, single-blind pilot study显示文摘 | TERKELTAUB R SUNDY J S SCHUMACHER H R | 2009 | Ann Rheum Dis2009，68，10： | 1 |
| 8 | Leukemia inhibitory factor, oncostatin M, IL - 6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy 显示文摘 | Sempowski GD Hale LP Sundy JS | 2000 | J Immunol2000，164，4： | 1 |
| 9 | Update on nonsteriodal anti-inflammatory drugs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr Opin Rheumatol2006，18，3： | 1 |
| 10 | Preliminarystudyonwheatcellwallcalmodulin显示文摘 | YeZH SunDY GuoJF | 1989 | ChinSciBull1989，34，： | 1 |
| 11 | Update on nonsteriodal anti-inflammatory drugs显示文摘 | Ardoin SP Sundy JS | | 0，，03： | 1 |
| 12 | Pharmacokineticsand pharmacodynamics of intravenous PEGylated recombinantmammalian urate oxidase in patients with refractory gout显示文摘 | SUNDY JS GANSON NJ KELLY SJ | 2007 | Ar-thritis Rheum2007，56，3： | 1 |
| 13 | Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout显示文摘 | Sundy JS Ganson NJ Kelly SJ | 2007 | Arthritis Rheum2007，56，： | 1 |
| 14 | Youth and suicide prevention 显示文摘 | Kuteh ERSP Sundi ALSM | 2008 | CMAJ2008，178，： | 1 |
| 15 | Reduction ofplasma urate levels following treatment with multiple doses of pe-gloticase(polyethylene glycol-conjugated uricase)in patientswith treatment-failure gout:results of a phase II randomized study显示文摘 | SUNDY JS BECKER MA BARAF HS | 2008 | Arthritis Rheum2008，58，9： | 1 |
| 16 | Update on nonsteriodal anti-inflammato- ry drugs 显示文摘 | Ardoin S P Sundy J S | 2006 | Current opinion in rheumatology2006，18，3： | 1 |
| 17 | Efficacy andsafety of intravenous(IV)pegloticase(PGL)in subjects withtreatment failure gout(TFG):Phase 3 results from GOUT1 andGOUT2显示文摘 | SUNDY JS BARAF HS BECKER MA | 2008 | Arthritis Rheum2008，58，9： | 1 |
| 18 | Uricase and other novel agents for the management of patients with treatment-failure gout显示文摘 | John S. Sundy MD PhD Michael S. Hershfield MD | 2007 | Current Rheumatology Reports2007，，3： | 1 |
| 19 | Chro-nic use of pegloticase:safety and efficacy update显示文摘 | SUNDY JS BARAF HS GUTIERREZ-URENA SR | 2009 | ArthritisRheum2009，60，10： | 1 |
| 20 | The combination of tranilast with allopurinol results in enhanced urate-lowering 显示文摘 | Sundy JS Kitt M Griffith SG | 2010 | Arthritis Rheum2010，62，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员